血蛋白质学用于预测亚临床冠状动脉化在初级预防中的预测

Patrick Royer1, Elias Björnson2, Martin Adiels3

  • 1Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Clinical Physiology, Gothenburg, Sweden; Department of Critical Care, University Hospital of Martinique, Fort-de-France, France.

American heart journal
|February 7, 2024
PubMed
概括

这项研究发现,在无症状个体中,血蛋白子集并没有改善冠状动脉化 (CAC) 的预测,超出了传统的风险因素. 蛋白质组没有为检测亚临床CAC增加价值.